Search Results

Morbidity Involving the Hallucinogenic Designer Amines MDA and 2C-I

Authors: Drees, Julia C.; Stone, Judy A.; Wu, Alan H. B.

Source: Journal of Forensic Sciences, Volume 54, Number 6, November 2009 , pp. 1485-1487(3)

Publisher: Blackwell Publishing

Metabolic interactions with piperazine-based `party pill' drugs

Authors: Antia, Ushtana; Tingle, Malcolm D.; Russell, Bruce R.

Source: Journal of Pharmacy and Pharmacology, Volume 61, Number 7, July 2009 , pp. 877-882(6)

Publisher: Pharmaceutical Press

Managing young people with Type 1 diabetes in a `rave' new world: metabolic complications of substance abuse in Type 1 diabetes

Authors: Lee, P.; Greenfield, J. R.; Campbell, L. V.

Source: Diabetic Medicine, Volume 26, Number 4, April 2009 , pp. 328-333(6)

Publisher: Blackwell Publishing

Review of: Mass Spectra of Designer Drugs 2008 CD-ROM

Author: Dal Cason, Terry A.

Source: Journal of Forensic Sciences, Volume 54, Number 2, March 2009 , pp. 497-498(2)

Publisher: Blackwell Publishing

Moving Forward - Essential Questions for the Next 10 Years

Authors: Lipton, Richard B.; Sheftell, Fred D.

Source: Headache: The Journal of Head and Face Pain, Volume 49, Supplement 1, February 2009 , pp. S43-S46(1)

Publisher: Blackwell Publishing

Designer Peptides: Learning from Nature

Authors: Shrivastava, A.; Nunn, A. D.; Tweedle, M. F.

Source: Current Pharmaceutical Design, Volume 15, Number 6, February 2009 , pp. 675-681(7)

Publisher: Bentham Science Publishers

Genetically Engineered Mouse Models of Brain Cancer and the Promise of Preclinical Testing

Authors: Huse, Jason T.; Holland, Eric C.

Source: Brain Pathology, Volume 19, Number 1, January 2009 , pp. 132-143(12)

Publisher: Blackwell Publishing

ReviewThe impact of alcopops on adolescent drinking: a literature review

Authors: Metzner, Cornelia; Kraus, Ludwig

Source: Alcohol and Alcoholism, Volume 43, Number 2, 17 October 2008 , pp. 230-239(10)

Publisher: Oxford University Press

Designer Therapies for Glioblastoma Multiforme

Authors: Sathornsumetee, Sith; Rich, Jeremy N.

Source: Annals of the New York Academy of Sciences, Volume 1142, Number 1, October 2008 , pp. 108-132(25)

Publisher: Blackwell Publishing

TECHNICAL NOTE: Detection of 1-Benzylpiperazine and 1-(3-Trifluoromethylphenyl)-piperazine in Urine Analysis Specimens Using GC-MS and LC-;ESI-MS

Authors: Vorce, Shawn P.; Holler, Justin M.; Levine, Barry; Past, Marilyn R.

Source: Journal of Analytical Toxicology, Volume 32, Number 6, July/August 2008 , pp. 444-450(7)

Publisher: Preston Publications

Designer monoclonal antibodies as drugs: the state of the art

Authors: Mohapatra, Shyam; Juan, Homero San

Source: Expert Review of Clinical Immunology, Volume 4, Number 3, May 2008 , pp. 305-307(3)

Publisher: Expert Reviews

Development and Clinical Application of an LC-MS-MS Method for Mescaline in Urine

Authors: Björnstad, Kristian; Helander, Anders; Beck, Olof

Source: Journal of Analytical Toxicology, Volume 32, Number 3, April 2008 , pp. 227-231(5)

Publisher: Preston Publications

Androgen abuse in sports

Authors: Handelsman, David J.; Heather, Alison

Source: Asian Journal of Andrology, Volume 10, Number 3, May 2008 , pp. 403-415(13)

Publisher: Blackwell Publishing

An announced suicide with ecstasy

Authors: Libiseller, Kathrin; Pavlic, Marion; Grubwieser, Petra; Rabl, Walter

Source: International Journal of Legal Medicine, Volume 121, Number 1, January 2007 , pp. 40-43(4)

Publisher: Springer

Review of: Mass Spectra of Designer Drugs: Including Precursors, Medicinal Drugs and Chemical Warfare Agents

Author: Kerrigan, Sarah

Source: Journal of Forensic Sciences, Volume 52, Number 6, November 2007 , pp. 1422-1422(1)

Publisher: Blackwell Publishing

Stability of analytes in biosamples—an important issue in clinical and forensic toxicology?

Author: Peters, Frank

Source: Analytical and Bioanalytical Chemistry, Volume 388, Number 7, August 2007 , pp. 1505-1519(15)

Publisher: Springer

Peter Rösner, Thomas Junge, Folker Westphal, Giselher Fritschi: Mass spectra of designer drugs including drugs, chemical warfare agents, and precursors

Author: Maurer, Hans

Source: Analytical and Bioanalytical Chemistry, Volume 388, Number 7, August 2007 , pp. 1313-1314(2)

Publisher: Springer

Identification and quantitative determination of 5-methoxy-N,N-di-n-propyltryptamine in urine by isotope dilution gas chromatography-mass spectrometry

Authors: Nakamoto, Akihiro; Namera, Akira; Nishida, Manami; Yashiki, Mikio; Kuramoto, Takako; Kimura, Kojiro

Source: Forensic Toxicology, Volume 25, Number 1, June 2007 , pp. 1-7(7)

Publisher: Springer

N-Dealkylation of Arylpiperazine Derivatives: Disposition and Metabolism of the 1-Aryl-Piperazines Formed

Author: Silvio Caccia,

Source: Current Drug Metabolism, Volume 8, Number 6, August 2007 , pp. 612-622(11)

Publisher: Bentham Science Publishers

Immunomodulatory Effects of Macrolide Antibiotics in Respiratory Disease: Therapeutic Implications for Asthma and Cystic Fibrosis

Authors: Sharma, Sanjiv; Jaffe, Adam; Dixon, Garth

Source: Pediatric Drugs, Volume 9, Number 2, 2007 , pp. 107-118(12)

Publisher: Adis International